| Literature DB >> 26068987 |
Daniel Metzger1, Pierre Chambon1.
Abstract
The generation of ligand-activated site-specific Cre recombinases has led to the development of cell type-specific temporally controlled targeted somatic mutagenesis in the mouse. We illustrate this technique using K14-Cre-ER(T2) transgenic mice that express the tamoxifen (tam)-activatable Cre-ER(T2) recombinase in epidermal basal keratinocytes to induce mutations in epidermal keratinocytes of adult mice. Our highly reproducible technique, based on induction of Cre-ER(T2) recombinase activity by tamoxifen administration at low doses (once daily 100-µg intraperitoneal injection for 5 days), has allowed the generation of site-directed somatic mutations of numerous genes in mouse epidermal keratinocytes, and several mouse models of human diseases. The present step-by-step protocol describes how to introduce temporally controlled targeted mutations in epidermal keratinocytes of adult mice. Curr. Protoc. Mouse Biol. 1:55-70. © 2011 by John Wiley & Sons, Inc.Entities:
Keywords: Cre-ERT2; keratinocytes; loxP; skin; tamoxifen
Year: 2011 PMID: 26068987 DOI: 10.1002/9780470942390.mo100128
Source DB: PubMed Journal: Curr Protoc Mouse Biol ISSN: 2161-2617